Edinburgh Airport Selects Leidos Antimicrobial Security Tray Technology

Rhea-AI Summary

Leidos (NYSE:LDOS) has secured a prime contract with Edinburgh Airport Limited to enhance its security tray systems by implementing antimicrobial technology. This technology reduces bacteria like E. coli and MRSA by 99.99%, addressing health concerns amid the ongoing pandemic. Leidos has collaborated with Edinburgh Airport since 2012 and aims to support improved health safety for travelers. The company reported revenues of approximately $11.09 billion for the fiscal year ending January 3, 2020, and has a strong portfolio of security detection solutions deployed in over 120 countries.

Positive

• Awarded a prime contract with Edinburgh Airport for antimicrobial security tray systems.
• Antimicrobial trays reduce bacteria by 99.99%, enhancing health safety.
• Strong historical collaboration with Edinburgh Airport since 2012.

Negative

• None.

RESTON, Va., June 23, 2020 /PRNewswire/ -- Leidos (NYSE:LDOS), a FORTUNE^® 500 science and technology leader, was awarded a prime contract by Edinburgh Airport Limited (Edinburgh Airport) to upgrade the airport's security tray return systems with antimicrobial tray technology. The implementation of antimicrobial technology complements other measures Edinburgh Airport is taking to minimize the spread of bacteria in the airport. This is Leidos' first order of the antimicrobial security tray technology introduced to mitigate the spread of bacteria from person-to-surface contact.  

"Edinburgh Airport's leadership recognizes the increased risk of the virus spreading from the number of travelers and staff handling security trays every day, and I commend them for implementing antimicrobial security tray technology," said Maria Hedden, senior vice president and operation manager for Leidos' Security Detection and Automation Operation. "Leidos is proud to support the place where Scotland meets the world with security detection and automation technology solutions that are fast, frictionless and fully integrated."

Edinburgh Airport is Scotland's busiest airport, and the sixth busiest airport in the United Kingdom. The airport remains operational during the coronavirus pandemic, with airport officials enacting plans to safeguard the health of its staff and the traveling public while preparing for global travel recovery. Working with Leidos since 2012, Edinburgh Airport utilizes the company's intelligent automated tray return systems as well as desktop real-time explosives detection systems.

Under the contract, Leidos will provide new antimicrobial security trays that prevent reproduction of a broad spectrum of bacteria, including staphylococcus aureus (staph), E. coli, and antibiotic-resistant bacteria like MRSA and VRE, by 99.99%. The antimicrobial technology is built into the security tray during Leidos' tray manufacturing process and continuously minimizes the presence of microbes throughout the security tray's lifecycle. The antimicrobial security trays must be cleaned according to normal hygiene procedures, but the additive will not wash off or wear away. The use of antimicrobial technology is important because studies have shown that microbes can survive on surfaces for up to eight weeks.

These antimicrobial security trays are the latest offering in Leidos' comprehensive security detection and automation solutions for aviation, ports, borders, and critical infrastructure. Learn more about the company's 24,000 security detection and automation products, which are deployed in 120 countries and territories at leidos.com/security-detection.

About Leidos
Leidos is a Fortune 500^® information technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 37,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Va., Leidos reported annual revenues of approximately $11.09 billion for the fiscal year ended January 3, 2020. For more information, visit www.Leidos.com.

Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended January 3, 2020, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.

Contact: 
Melissa Dueñas
(571) 526-6011
Duenasml@leidos.com                                                

Thomas Doheny
(571) 474-4735
dohenyt@leidos.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/edinburgh-airport-selects-leidos-antimicrobial-security-tray-technology-301081273.html

SOURCE Leidos

FAQ

What contract did Leidos win with Edinburgh Airport?

Leidos won a prime contract to upgrade Edinburgh Airport's security tray systems with antimicrobial technology.

How effective is the antimicrobial technology provided by Leidos?

The antimicrobial technology reduces the presence of bacteria like E. coli and MRSA by 99.99%.

What was Leidos' revenue for the fiscal year ending January 2020?

Leidos reported annual revenues of approximately $11.09 billion for the fiscal year ending January 3, 2020.

How does the antimicrobial tray technology work?

The antimicrobial technology is integrated into the trays during manufacturing, continuously minimizing microbes throughout the trays' lifecycle.

What is the significance of this contract for Leidos investors?

This contract demonstrates Leidos' ongoing growth in the security technology sector and reinforces its commitment to health safety, potentially benefiting investors.